July 2022 Publications
- Role of antibodies in vaccine-mediated protection against tuberculosis. Dieli F, Ivanyi J. Cell Mol Immunol. 2022 Jul. doi: 10.1038/s41423-022-00861-6. Epub 2022 Apr 8.
- Towards building a tuberculosis free world. Mandal S. Indian J Tuberc. 2022 Jul. doi: 10.1016/j.ijtb.2021.08.018. Epub 2021 Aug 17.
- Transcriptomics for child and adolescent tuberculosis. Kaforou M, Broderick C, Vito O, Levin M, Scriba TJ, Seddon JA. Immunol Rev. 2022 Aug. doi: 10.1111/imr.13116. Epub 2022 Jul 12.
- Investing in late-stage clinical trials and manufacturing of product candidates for five major infectious diseases: a modelling study of the benefits and costs of investment in three middle-income countries. Schäferhoff M, Zimmerman A, Diab MM, Mao W, Chowdhary V, Gill D, Karanja R, Madikizela M, Ogbuoji O, Yamey G. Lancet Glob Health. 2022 Jul. doi: 10.1016/S2214-109X(22)00206-6.
- Genetic and hormonal mechanisms underlying sex-specific immune responses in tuberculosis. Gupta M, Srikrishna G, Klein SL, Bishai WR. Trends Immunol. 2022 Aug. doi: 10.1016/j.it.2022.06.004. Epub 2022 Jul 13.
- Structural analysis and simulation of solid microneedle array for vaccine delivery applications. S B V J C, Mannayee G. Mater Today Proc. 2022 Jul 13. doi: 10.1016/j.matpr.2022.06.483. Online ahead of print.
- Evaluating the Performance of PPE44, HSPX, ESAT-6 and CFP-10 Factors in Tuberculosis Subunit Vaccines. Valizadeh A, Imani Fooladi AA, Sedighian H, Mahboobi M, Gholami Parizad E, Behzadi E, Khosravi A. Curr Microbiol. 2022 Jul 19. doi: 10.1007/s00284-022-02949-8.
- Immune Correlates of Disseminated BCG Infection in IL12RB1-Deficient Mice. Wang X, Jia L, Liu Y, Wang J, Qiu C, Li T, Zhang W, Zhu Z, Wu J, Wan Y. Vaccines (Basel). 2022 Jul 19. doi: 10.3390/vaccines10071147.
- Past, Present and Future of Bacillus Calmette-Guérin Vaccine Use in China. Li J, Lu J, Wang G, Zhao A, Xu M. Vaccines (Basel). 2022 Jul 20. doi: 10.3390/vaccines10071157.
- Development of a rapid in vitro pre-screen for distinguishing effective liposome-adjuvant delivery systems. Feather LAJ, Nadella V, Kastner E, Perrie Y, Hilton AC, Devitt A. Sci Rep. 2022 Jul 20. doi: 10.1038/s41598-022-14449-7.
- Evaluation of early innate and adaptive immune responses to the TB vaccine Mycobacterium bovis BCG and vaccine candidate BCGΔBCG1419c. Gunasena M, Shukla RK, Yao N, Rosas Mejia O, Powell MD, Oestreich KJ, Aceves-Sánchez MJ, Flores-Valdez MA, Liyanage NPM, Robinson RT. Sci Rep. 2022 Jul 20. doi: 10.1038/s41598-022-14935-y.
- Immune evasion and provocation by Mycobacterium tuberculosis. Chandra P, Grigsby SJ, Philips JA. Nat Rev Microbiol. 2022 Jul 25. doi: 10.1038/s41579-022-00763-4. Online ahead of print.
- Increased Heme Oxygenase 1 Expression upon a Primary Exposure to the Respiratory Syncytial Virus and a Secondary Mycobacterium bovis Infection. Canedo-Marroquín G, Soto JA, Andrade CA, Bueno SM, Kalergis AM. Antioxidants (Basel). 2022 Jul 26. doi: 10.3390/antiox11081453.
- Induction of Cross-Reacting Antibodies Against the COVID-19 by BCG Vaccination in the Mouse Model. Rahali N, Bahloul C. Curr Microbiol. 2022 Jul 30. doi: 10.1007/s00284-022-02971-w.